Sanofi Genzyme competitorsClear all

Sanofi Genzyme's top competitors include Biogen, Amgen, Amicus Therapeutics and Haihe Biopharma.
Discover new suppliers and conduct deeper comparison analysis with Craft for EnterpriseLearn more
Banner background
Sanofi Genzyme
Sanofi Genzyme
Sanofi Genzyme (also known as Genzyme Corporation) is a biotech company that specializes in rare diseases, rare blood disorders, multiple sclerosis, oncology, and immunology.
Biogen
Biogen
Biogen is a biopharmaceutical company that discovers, develops, and delivers innovative therapies for people living with serious neurological and neurodegenerative diseases.
Amgen
Amgen
Amgen (formerly known as Applied Molecular Genetics) is a biotech company discovering, developing, manufacturing, and delivering human therapeutics products.
Amicus Therapeutics
Amicus Therapeutics
Amicus Therapeutics is a biopharmaceutical company developing therapies for the treatment of rare and orphan diseases.
Haihe Biopharma
Haihe Biopharma
Haihe Biopharma is a company that develops anti-tumor drugs designed to overcome complex diseases and improve pharmacological evaluation.
Founding Date
Founding Date
1981
Founding Date
1978
Founding Date
1980
Founding Date
2002
Founding Date
2011
Type
Type
Subsidiary
Type
Public
Type
Public
Type
Public
Type
Private
Tags
Locations
Locations
Cambridge, US HQ
Macquarie Park, AU
Malaga, AU
Virginia, AU
São Paulo, BR
Mississauga, CA
Toronto, CA
see more
Locations
Cambridge, US HQ
Vicente López, AR
Macquarie Park, AU
Wien, AT
Machelen, BE
Mississauga, CA
Las Condes, CL
see more
Locations
Thousand Oaks, US HQ
Hydra, DZ
Vicente López, AR
Kew, AU
North Ryde, AU
Wien, AT
Machelen, BE
see more
Locations
Philadelphia, US HQ
Northbridge, AU
Pointe Claire, CA
Paris, FR
München, DE
Dublin, IE
Milano, IT
see more
Locations
CN HQ
Employees
Employees
10,065
Employees
7,4005% decrease
Employees
24,3004% increase
Employees
58415% increase
Employees
254% increase
Valuation ($)
Valuation ($)
N/A
Valuation ($)
39.9 b
Valuation ($)
120.2 b
Valuation ($)
2.8 b
Valuation ($)
N/A
Twitter followers
Twitter followers
59.3 k
Twitter followers
41.4 k
Twitter followers
102.9 k
Twitter followers
1.9 k
Twitter followers
N/A
Number of tweets (last 30 days)
Number of tweets (last 30 days)
15
Number of tweets (last 30 days)
62
Number of tweets (last 30 days)
132
Number of tweets (last 30 days)
17
Number of tweets (last 30 days)
N/A
Average likes per tweet (last 30 days)
Average likes per tweet (last 30 days)
2.4
Average likes per tweet (last 30 days)
16.3
Average likes per tweet (last 30 days)
5.8
Average likes per tweet (last 30 days)
2.3
Average likes per tweet (last 30 days)
N/A
Percentage of tweets with engagement (last 30 days)
Percentage of tweets with engagement (last 30 days)
86.67%
Percentage of tweets with engagement (last 30 days)
100%
Percentage of tweets with engagement (last 30 days)
94.7%
Percentage of tweets with engagement (last 30 days)
94.12%
Percentage of tweets with engagement (last 30 days)
N/A
Alexa Website Rank
Alexa Website Rank
N/A
Alexa Website Rank
252167
Alexa Website Rank
149411
Alexa Website Rank
307711
Alexa Website Rank
N/A
Employee Rating
Employee Rating
N/A
Employee Rating
4.1
Employee Rating
4.1
Employee Rating
3.3
Employee Rating
N/A

Financial

Revenue (est.)
Revenue (est.)
€10.4b (FY, 2019)
Revenue (est.)
$13.4b (FY, 2020)
Revenue (est.)
$25.4b (FY, 2020)
Revenue (est.)
$260.9m (FY, 2020)
Revenue (est.)
N/A
Cost of goods
Cost of goods
N/A
Cost of goods
$1.8b (FY, 2020)
Cost of goods
$6.2b (FY, 2020)
Cost of goods
$31m (FY, 2020)
Cost of goods
N/A
Gross profit
Gross profit
N/A
Gross profit
$11.6b (FY, 2020)
Gross profit
$19.3b (FY, 2020)
Gross profit
$229.8m (FY, 2020)
Gross profit
N/A
Net income
Net income
N/A
Net income
$4.1b (FY, 2020)
Net income
$7.3b (FY, 2020)
Net income
($276.9m) (FY, 2020)
Net income
N/A

Operating

Countries
Countries
100 (Nov, 2020)
Countries
N/A
Countries
100 (FY, 2020)
Countries
N/A
Countries
N/A
Patents (US)
Patents (US)
605 (Nov, 2020)
Patents (US)
21 (FY, 2019)
Patents (US)
31 (FY, 2020)
Patents (US)
N/A
Patents (US)
N/A
Phase I Trials Products
Phase I Trials Products
N/A
Phase I Trials Products
13 (Q3, 2020)
Phase I Trials Products
20 (FY, 2020)
Phase I Trials Products
N/A
Phase I Trials Products
N/A
Phase II Trials Products
Phase II Trials Products
N/A
Phase II Trials Products
9 (Q3, 2020)
Phase II Trials Products
5 (FY, 2020)
Phase II Trials Products
N/A
Phase II Trials Products
N/A
Phase III Trials Products
Phase III Trials Products
N/A
Phase III Trials Products
6 (Q3, 2020)
Phase III Trials Products
11 (FY, 2020)
Phase III Trials Products
N/A
Phase III Trials Products
N/A

Funding

Total funding raised
Total funding raised
N/A
Total funding raised
N/A
Total funding raised
N/A
Total funding raised
$ 88m
Total funding raised
$ 317.6m
For sources of this data, please see the company profile

View company profiles

Biogen
HQ
Cambridge, US
Employees
7,400↓ 5% decrease

Biogen is a biopharmaceutical company that discovers, develops, and delivers innovative therapies for people living with serious neurological and neurodegenerative diseases.

View company
Amgen
HQ
Thousand Oaks, US
Employees
24,300↑ 4% increase

Amgen (formerly known as Applied Molecular Genetics) is a biotech company discovering, developing, manufacturing, and delivering human therapeutics products.

View company
Amicus Therapeutics
HQ
Philadelphia, US
Employees
584↑ 15% increase

Amicus Therapeutics is a biopharmaceutical company developing therapies for the treatment of rare and orphan diseases.

View company
Haihe Biopharma
HQ
CN
Employees
25↑ 4% increase

Haihe Biopharma is a company that develops anti-tumor drugs designed to overcome complex diseases and improve pharmacological evaluation.

View company